We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Orchard Therapeutics said it intended to use some of the proceeds of an IPO to build a manufacturing facility for its gene therapies program and now it is.